Follow
Viswanadh MK
Viswanadh MK
Associate Professor, KL College of Pharmacy, KL Deemed to be University, Vijayawada, AP
Verified email at itbhu.ac.in
Title
Cited by
Cited by
Year
Nanotheranostics: emerging strategies for early diagnosis and therapy of brain cancer
MK Viswanadh, RP Singh, P Agrawal, AK Mehata, DM Pawde, R Sonkar, ...
Nanotheranostics 2 (1), 70, 2018
1302018
Trastuzumab decorated TPGS-g-chitosan nanoparticles for targeted breast cancer therapy
AK Mehata, S Bharti, P Singh, MK Viswanadh, L Kumari, P Agrawal, ...
Colloids and Surfaces B: Biointerfaces 173, 366-377, 2019
922019
EGFR targeted paclitaxel and piperine co-loaded liposomes for the treatment of triple negative breast cancer
AS Burande, MK Viswanadh, A Jha, AK Mehata, A Shaik, N Agrawal, ...
AAPS PharmSciTech 21, 1-12, 2020
542020
Bioadhesive chitosan nanoparticles: Dual targeting and pharmacokinetic aspects for advanced lung cancer treatment
MK Viswanadh, AK Mehata, V Sharma, V Priya, N Varshney, SK Mahto, ...
Carbohydrate Polymers 274, 118617, 2021
412021
Mannose receptor targeted bioadhesive chitosan nanoparticles of clofazimine for effective therapy of tuberculosis
DM Pawde, MK Viswanadh, AK Mehata, R Sonkar, S Poddar, AS Burande, ...
Saudi Pharmaceutical Journal 28 (12), 1616-1625, 2020
412020
DNA biodots based targeted theranostic nanomedicine for the imaging and treatment of non-small cell lung cancer
A Jha, MK Viswanadh, AS Burande, AK Mehata, S Poddar, K Yadav, ...
International journal of biological macromolecules 150, 413-425, 2020
322020
Gold liposomes for brain-targeted drug delivery: Formulation and brain distribution kinetics
R Sonkar, A Jha, MK Viswanadh, AS Burande, DM Pawde, KK Patel, ...
Materials Science and Engineering: C 120, 111652, 2021
282021
Novel redox-sensitive thiolated TPGS based nanoparticles for EGFR targeted lung cancer therapy
MK Viswanadh, N Agrawal, S Azad, A Jha, S Poddar, SK Mahto, ...
International Journal of Pharmaceutics 602, 120652, 2021
272021
Formulation and in vivo efficacy study of cetuximab decorated targeted bioadhesive nanomedicine for non-small-cell lung cancer therapy
MK Viswanadh, Vikas, A Jha, SK Reddy Adena, AK Mehata, V Priya, ...
Nanomedicine 15 (24), 2345-2367, 2020
272020
WNT-β catenin signaling as a potential therapeutic target for neurodegenerative diseases: current status and future perspective
K Ramakrishna, LV Nalla, D Naresh, K Venkateswarlu, MK Viswanadh, ...
Diseases 11 (3), 89, 2023
232023
Upconversion nanotheranostics: emerging designs for integration of diagnosis and therapy
MS Muthu, AK Mehata, MK Viswanadh
Nanomedicine 12 (6), 577-580, 2017
182017
Theranostic magnetic nanoparticles: Synthesis, properties, toxicity, and emerging trends for biomedical applications
A Setia, AK Mehata, AK Malik, MK Viswanadh, MS Muthu
Journal of Drug Delivery Science and Technology 81, 104295, 2023
172023
Fast and highly efficient liquid chromatographic methods for qualification and quantification of antibiotic residues from environmental waste
AK Mehata, MNL Suseela, P Gokul, AK Malik, MK Viswanadh, C Singh, ...
Microchemical Journal 179, 107573, 2022
172022
Formulation and in vitro evaluation of upconversion nanoparticle-loaded liposomes for brain cancer
Narendra, AK Mehata, MK Viswanadh, R Sonkar, DM Pawde, V Priya, ...
Therapeutic Delivery 11 (9), 557-571, 2020
162020
Dendritic cell-targeted theranostic nanomedicine: advanced cancer nanotechnology for diagnosis and therapy
AK Mehata, MK Viswanadh, V Priya, Vikas, MS Muthu
Nanomedicine 15 (10), 947-949, 2020
162020
Targeted bioadhesive nanomedicine: an effective approach for synergistic drug delivery to cancers
MK Viswanadh, MS Muthu
Nanomedicine 13 (12), 1401-1403, 2018
162018
Advances in solid-phase extraction techniques: Role of nanosorbents for the enrichment of antibiotics for analytical quantification
MNL Suseela, MK Viswanadh, AK Mehata, V Priya, A Setia, AK Malik, ...
Journal of Chromatography A 1695, 463937, 2023
142023
Physical and in-vitro evaluation of ϵ-Fe3N@ Fe3O4 nanoparticles for bioapplications
A Gangwar, SS Varghese, SS Meena, CL Prajapat, MK Viswanadh, ...
Ceramics International 46 (8), 10952-10962, 2020
142020
Structural and in-vitro assessment of ZnxFe3− xC (0≤ x≤ 1) nanoparticles as magnetic biomaterials
A Gangwar, S Kumar, SS Meena, A Sharma, MK Viswanadh, K Neogi, ...
Applied Surface Science 509, 144891, 2020
122020
Targeted nanotherapeutics in the prophylaxis and treatment of thrombosis
V Priya, MK Viswanadh, AK Mehata, D Jain, SK Singh, MS Muthu
Nanomedicine 16 (13), 1153-1176, 2021
92021
The system can't perform the operation now. Try again later.
Articles 1–20